Tjoapack successfully launches its first Pre-Filled Syringe (PFS) project, expanding its packaging capabilities with advanced automation and safety features to meet growing market demand.
The pharma industry has experienced significant changes in the past five years, with the COVID-19 pandemic and regional conflicts causing significant disruption to the supply chain of packaged drug products.
Artificial intelligence (AI), blockchain and automation have the potential to streamline the pharmaceutical packaging process and optimize traceability of finished units. The use of new packaging materials can minimise the industry’s carbon footprint
Discover profound insights from Tjoapack US President Peter Belden as he elucidates the attainment of sustainability and integrity through optimal packaging and supply chain solutions.
Gain valuable insights from our Director of Engineering, Boy Tjoa, as he discusses with CPHI Online the prospective impact of robotics within pharmaceutical manufacturing, elucidating the imminent challenges and rewards poised to revolutionize...
In the run-up to CPHI Barcelona, Dexter Tjoa, CEO of Tjoapack, looks at innovations shaping the future of healthcare packaging. In this first blog in the series, he explores how partnerships with packaging experts are helping companies transform...
Get Ready for a Deep Dive into Drug Development! Join us on October 20th for an exclusive Molecule to Market podcast episode featuring Peter Belden, President of Tjoapack US, as we unravel the outsourcing secrets in the global drug development sector
Revolutionary patient-centric development and pre-filled syringe packagingNew advancements in the field of pharma packaging are revolutionising the healthcare industry, setting the stage for a more efficient and sustainable future.
Today, Monday, November 6, marks ERT (Emergency Response Team) Day, which we actively engage in at Tjoapack. Safety is paramount to our organization, continually addressed in our training programs and meetings.
Ready to shape the future of your pharmaceutical supply chain?